Medicure Inc. (CVE:MPH – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 606 shares. The stock had previously closed at C$0.83.
Medicure Stock Performance
The firm has a market cap of C$7.93 million, a P/E ratio of -3.04 and a beta of 0.90. The company has a quick ratio of 1.29, a current ratio of 1.87 and a debt-to-equity ratio of 2.06. The business has a fifty day simple moving average of C$0.88 and a 200-day simple moving average of C$0.94.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Five stocks we like better than Medicure
- Investing In Preferred Stock vs. Common Stock
- 3 Must-Have ETFs Set to Dominate This Quarter
- What Are Some of the Best Large-Cap Stocks to Buy?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
